Bixia Xuan

Comparison of Efficacy and Safety Between Immunotherapy and Docetaxel Monotherapy in NSCLC Patients

Yefei Zhang, Haiyan Si, Mengqi Chen, 2022, Frontiers in Oncology.

Therapeutic potential of 1,2,3‐triazole hybrids for leukemia treatment

Haiyan Si, Wenchao Yang, Bixia Xuan, 2022, Archiv der Pharmazie.

Distribution, diagnosis, and analysis of related risk factors of multidrug-resistant organism in patients with malignant neoplasms.

Liuping Zhang, Wenchao Yang, Bixia Xuan, 2020, International journal of clinical and experimental pathology.

New flavonoids from Campylotropis hirtella with immunosuppressive activity.

Zhengwu Shen, Bixia Xuan, Qingyao Shou, 2014, Fitoterapia.

Immunosuppressive chalcone-isoflavonoid dimers from Campylotropis hirtella

Zhengwu Shen, Lijuan Xia, Bixia Xuan, 2016 .

Assessment of the prognostic value of SPOCK1 in clear cell renal cell carcinoma: a bioinformatics analysis

Ziqi Ye, Jie Chen, Lulu Liu, 2021, Translational andrology and urology.

Efficacy and Safety Evaluation of Sintilimab for Cancer Treatment: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Ziqi Ye, Haiyan Si, Wenchao Yang, 2022, Frontiers in Pharmacology.